The insurer plans to redeploy proceeds from about US$25bn in cross-shareholding sales, as Japanese regulators press major carriers to cut legacy equity stakes and improve capital efficiency.
The deal, which is set to be completed in October, covers policy reserves of approx. ¥310bn (US$2.09bn), with Swiss Re retroceding all mortality risk associated with the portfolio